Key Quantitative Figures

Consolidated Financial Results (Q1 FY27):

  • Revenue from operations: ₹1,906.83 lakh
  • Other income: ₹131.53 lakh
  • Total income: ₹2,038.36 lakh
  • Total expenses: ₹1,282.47 lakh
  • Profit before tax: ₹755.89 lakh
  • Tax expense: ₹192.03 lakh (Current tax: ₹187.40 lakh, Deferred tax: ₹4.63 lakh)
  • Net profit: ₹563.86 lakh
  • Basic and diluted EPS: ₹4.70
  • Paid-up equity share capital: ₹1,200.30 lakh
  • Reserves: ₹11,279.52 lakh (as of March 31, 2026)

Standalone Financial Results (Q1 FY27):

  • Revenue from operations: ₹1,944.33 lakh
  • Other income: ₹133.07 lakh
  • Total income: ₹2,077.40 lakh
  • Total expenses: ₹1,307.14 lakh
  • Profit before tax: ₹770.26 lakh
  • Tax expense: ₹192.03 lakh (Current tax: ₹187.40 lakh, Deferred tax: ₹4.63 lakh)
  • Net profit: ₹578.23 lakh
  • Basic and diluted EPS: ₹4.82
  • Paid-up equity share capital: ₹1,200.30 lakh
  • Reserves: ₹11,382.01 lakh (as of March 31, 2026)

Dates of Action

  • Board meeting date: August 11, 2026
  • Meeting duration: 3:15 PM to 3:50 PM
  • Quarter ended: June 30, 2026
  • Financial year ended: March 31, 2026

Parties Involved

  • Prevest Denpro Limited (Holding Company)
  • Denvisio Biomed Limited (Wholly owned subsidiary)
  • Axiodent Inc. (Wholly owned foreign subsidiary)
  • Prevest Denpro Gulf General Trading LLC (Wholly owned foreign subsidiary)
  • Mittal & Associates (Statutory auditors)
  • BSE Limited (Stock exchange)

Dividend Declaration

Recommended payment of Final Dividend on Equity Shares at the rate of 10% (₹1.00 per equity share of face value ₹10 each) for FY26, subject to shareholder approval at the ensuing Annual General Meeting.

Financial Impact Disclosure

The Company implemented Labour Codes notified by Government of India on November 21, 2025, with effect from April 1, 2026. This increased employee benefit expense by ₹227.80 lakh for the quarter, recognized based on best information currently available.

Other Approvals

  • Notice of 27th Annual General Meeting
  • Directors' Report
  • Management Discussion and Analysis Report for FY26

Foreign Subsidiaries Impact

Financial results of wholly owned foreign subsidiaries (Axiodent Inc. and Prevest Denpro Gulf General Trading LLC) include total revenue of ₹5.71 lakh and total net loss after tax of ₹16.81 lakh for the quarter. These were reviewed by parent management and considered not material to the Group.

Audit Status

Both consolidated and standalone financial results were reviewed by the Audit Committee, approved by the Board of Directors, and subjected to limited review by statutory auditors Mittal & Associates.

#Tags: #PrevestDenpro #Q1Results #Dividend #SEBIDisclosure #RegulatoryCompliance #FinancialUpdate #Neutral